---
title: "HRD test"
author: "Jun Kang"
date: '2021 8 6 '
output: pdf_document
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = TRUE)
```

## Myriad

[Myriad refers this article]https://clincancerres.aacrjournals.org/content/22/15/3764

cut-off: 42

![](img/telli.png)

\pagebreak

[Previous weighted model]https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-014-0475-x#additional-information

HRD‐model=0.11xHRD‐LOH+0.25xHRD‐TAI+0.12xHRD‐LST

![](img/Timms.png)

\pagebreak

## scarHRD
[scarHRD Github]https://github.com/sztup/scarHRD
[scarHRD article]https://www.nature.com/articles/s41523-018-0066-6  

![](img/scarHRD.png)

N.J.B., A.C.E., and Zo.S are listed as co-inventors on a patent on telomeric allelic imbalance, which is owned by Children’s Hospital Boston and licensed to Myriad Genetics. The remaining authors declare no competing interests.

\pagebreak

## HRDtools
[HRDtools Github]https://github.com/eyzhao/hrdtools
[HRDtools article]https://clincancerres.aacrjournals.org/content/23/24/7521.long

![](img/HRDtools.png)

K.A. Gelmon reports receiving speakers bureau honoraria from Astra Zeneca and Pfizer. S. Young reports receiving speakers bureau honoraria from and is a consultant/advisory board member for Astra-Zeneca. No potential conflicts of interest were disclosed by the other authors.

\pagebreak

## Remarks

- Myriad and scarHRD might be similar.
- Myriad program seems not to be publicaly opened.
- scarHRD might be a good option for research purpose. 
